CoDiagnostics, based in Salt Lake City, develops molecular tools for infectious disease detection, cancer screening, and agriculture, employing 155 staff. The company went public in July 2017 and is creating a portable diagnostic system for at-home use.
CODX has been in the news recently: Co-Diagnostics, Inc. has entered a securities purchase agreement to sell 12,727,272 shares at $0.55 each, aiming to raise approximately $7 million. Following this announcement, the company's shares fell over 50%, despite reporting a 15% increase in revenue for the quarter due to strong demand for its new product line.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.